Multiple Sclerosis International

Outcome Measures in Multiple Sclerosis


Publishing date
21 Jun 2013
Status
Published
Submission deadline
01 Feb 2013

Lead Editor

1Cleveland Clinic, Cleveland, OH, USA

2University of Pennsylvania School of Medicine, Philadelphia, PA, USA

3Johns Hopkins University School of Medicine, Baltimore, MD, USA


Outcome Measures in Multiple Sclerosis

Description

Multiple Sclerosis International aims to attract papers of high quality regarding outcome measures (clinical and paraclinical measures of disease activity or disease burden) in multiple sclerosis (MS). Of particular interest are new outcome measures, critical assessments of existing outcome measures, and outcome measures for use in pediatric MS. In addition, we welcome papers that specifically focus on how outcome measures are integrated into the clinical care of patients and into clinical trials. Potential topics include, but are not limited to:

  • Relapses
  • Clinical disability/disability progression
  • Gait
  • Balance
  • Strength
  • Sensation
  • Bladder/bowel
  • Vision (optical coherence tomography, evoked potentials)
  • Quality of life
  • Fatigue
  • Cognition
  • Depression
  • Pain and spasticity
  • MRI metrics (brain and spinal cord)
  • Integration of MS outcome measures into the clinical care setting

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/msi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 439375
  • - Editorial

Outcome Measures in Multiple Sclerosis

Robert Bermel | Amy Waldman | Ellen M. Mowry
  • Special Issue
  • - Volume 2014
  • - Article ID 262350
  • - Review Article

Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials

Amy M. Lavery | Leonard H. Verhey | Amy T. Waldman
  • Special Issue
  • - Volume 2013
  • - Article ID 481035
  • - Research Article

Integrity of the Anterior Visual Pathway and Its Association with Ambulatory Performance in Multiple Sclerosis

Swathi Balantrapu | Brian M. Sandroff | ... | Robert W. Motl
  • Special Issue
  • - Volume 2013
  • - Article ID 470476
  • - Clinical Study

Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study

Amy Perrin Ross | Alona Williamson | ... | Nicole Mutschler
  • Special Issue
  • - Volume 2013
  • - Article ID 190162
  • - Research Article

The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple Sclerosis

Neeta Kanekar | Alexander S. Aruin
  • Special Issue
  • - Volume 2013
  • - Article ID 756564
  • - Review Article

The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review

Luca Prosperini | Carlo Pozzilli
  • Special Issue
  • - Volume 2013
  • - Article ID 671730
  • - Review Article

DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications

Emilia Sbardella | Francesca Tona | ... | Patrizia Pantano
  • Special Issue
  • - Volume 2013
  • - Article ID 875648
  • - Research Article

Factors for Lower Walking Speed in Persons with Multiple Sclerosis

Leandro Alberto Calazans Nogueira | Luciano Teixeira dos Santos | ... | Luiz Claudio Santos Thuler
  • Special Issue
  • - Volume 2013
  • - Article ID 189624
  • - Clinical Study

Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis

Brian C. Healy | David Engler | ... | Tanuja Chitnis
  • Special Issue
  • - Volume 2013
  • - Article ID 524894
  • - Review Article

Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge

Karine Baumstarck | Laurent Boyer | ... | Pascal Auquier
Multiple Sclerosis International
 Journal metrics

Metrics will be available once more articles are published.

 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.